成纤维细胞生长因子23
急性肾损伤
医学
核受体
内科学
内分泌学
平衡
兴奋剂
肾
不利影响
受体
化学
转录因子
生物化学
甲状旁腺激素
基因
钙
作者
Kamalakannan Radhakrishnan,Yong‐Hoon Kim,Yoon Seok Jung,Don‐Kyu Kim,Soon‐Young Na,Daejin Lim,Dong Hun Kim,Jina Kim,Hyung-Seok Kim,Hyon E. Choy,Sung Jin Cho,In‐Kyu Lee,Şamil Ayvaz,Stefanie Nittka,Danilo Fliser,Stefan Schunk,Thimoteus Speer,Steven Dooley,Chul‐Ho Lee,Hueng‐Sik Choi
标识
DOI:10.1073/pnas.2022841118
摘要
Significance Bone is the main source of fibroblast growth factor 23 (FGF23), which is important for phosphate and vitamin D homeostasis. In acute kidney injury (AKI), high blood levels of FGF23 are positively correlated with disease progression and increased risk of mortality. Reducing adverse plasma FGF23 levels in AKI patients is favorable. We showed here that hepatocytes are the major source of circulating FGF23, and orphan nuclear receptor ERR-γ is a novel transcriptional regulator of hepatic FGF23 production in AKI. Liver-specific depletion of ERR-γ or ERR-γ inverse agonist, GSK5182, significantly reduced plasma levels of FGF23 in AKI. This study reveals liver is the source of FGF23 and a therapeutic strategy to control pathologically adverse plasma FGF23 levels in AKI.
科研通智能强力驱动
Strongly Powered by AbleSci AI